Filtered By:
Condition: Non-alcoholic Fatty Liver Diseases (NAFLD)

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 269 results found since Jan 2013.

Mayo Clinic Q & amp;A podcast: Cardiometabolic diseases increase COVID-19 risk
An estimated 47 million Americans are living with cardiometabolic diseases, according to the American College of Cardiology. Cardiometabolic diseases are interrelated conditions that include cardiovascular diseases, such as heart disease, stroke, and hypertension, as well as metabolic diseases, such as Type 2 diabetes, obesity and nonalcoholic fatty liver disease. Patients with cardiometabolic diseases have a [...]
Source: News from Mayo Clinic - November 13, 2020 Category: Databases & Libraries Source Type: news

HIIT for post-COVID patients within cardiac rehabilitation: Response to letter to the editor
We thank Li and colleagues for their comments regarding our recent research into the benefits of incorporating high-intensity interval training (HIIT) into cardiac rehabilitation for patients with coronary artery disease (CAD) [1]. In recent years, HIIT has proven popular in the general community and has been studied across a wide array of cardiovascular (CV)-related disorders, such as hypertension [2,3], stroke [4,5], type II diabetes [6] and non-alcoholic fatty liver disease [7]. This is due to compounding, compelling evidence of the efficacy of HIIT on CV outcomes such as reduced blood pressure, lowered body fat, improv...
Source: International Journal of Cardiology - August 29, 2020 Category: Cardiology Authors: Andrew Keech, Kimberley Way, Katie Holgate, Jennifer Fildes, Praveen Indraratna, Jennifer Yu Tags: Letter to the Editor Source Type: research

Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota.
Abstract Nonalcoholic steatohepatitis (NASH), a more advanced form of nonalcoholic fatty liver disease (NAFLD), is associated with increased cardiovascular and liver-related mortality. Stroke-prone spontaneously hypertensive rats (SHRSP5/Dmcr) that are fed a high-fat and high-cholesterol diet develop hepatic lesions that are similar to those observed in human NASH pathology. We investigated the hepatic protective and antioxidant effects of surface-deacetylated chitin nanofibers (SDACNFs) that were administered to SHRSP5/Dmcr rats for 8 weeks. The administration of SDACNFs (80 mg/kg/day) resulted in a significa...
Source: International Journal of Biological Macromolecules - July 18, 2020 Category: Biochemistry Authors: Goto M, Iohara D, Michihara A, Ifuku S, Azuma K, Kadowaki D, Maruyama T, Otagiri M, Hirayama F, Anraku M Tags: Int J Biol Macromol Source Type: research

Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV
Background: Nonalcoholic fatty liver disease (NAFLD) and HIV are independently associated with cardiovascular disease (CVD). However, the factors associated with NAFLD in persons living with HIV (PWH) and whether CVD is more frequent in PWH with NAFLD are currently unknown. Methods: From the Partners HealthCare Research Patient Data Registry, we identified PWH with and without NAFLD between 2010 and 2017. NAFLD was defined using validated histological or radiographic criteria. CVD was defined by an ICD-9 diagnosis of coronary artery disease, myocardial infarction, coronary revascularization, peripheral vascular diseas...
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes - June 25, 2020 Category: Infectious Diseases Tags: Clinical Science Source Type: research

The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extra-Hepatic Cancers
Publication date: Available online 20 May 2020Source: Journal of Clinical and Experimental HepatologyAuthor(s): Nicolette Veracruz, Bilal Hameed, Sammy Saab, Robert J. Wong
Source: Journal of Clinical and Experimental Hepatology - May 20, 2020 Category: Gastroenterology Source Type: research

Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study
Despite the known association between non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD), whether NAFLD predicts future CVD events, especially CVD mortality, remains uncertain. We evalu...
Source: Cardiovascular Diabetology - May 2, 2020 Category: Cardiology Authors: Jun Hyung Kim, Jin Sil Moon, Seok Joon Byun, Jun Hyeok Lee, Dae Ryong Kang, Ki Chul Sung, Jang Young Kim and Ji Hye Huh Tags: Original investigation Source Type: research

The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease
ConclusionUltrasonographically acquired HRI has a significant predictive impact on the detection of prediabetes and diabetes in patients with NAFLD.
Source: Indian Journal of Gastroenterology - March 16, 2020 Category: Gastroenterology Source Type: research

Mechanism of bariatric and metabolic surgery: beyond surgeons, gastroenterologists and endocrinologists.
Authors: Valentí V, Cienfuegos JA, Becerril Mañas S, Frühbeck G Abstract Bariatric-metabolic surgery is the safest, most effective and long-lasting treatment for obesity and its associated co-morbidities, whether they be metabolic (type 2 diabetes, hyperlipidemia non-alcoholic fatty liver disease) or cardiovascular (myocardial infarction, stroke). Due to the obesity pandemic, bariatric-metabolic surgery is the second most frequent intra-abdominal procedure and the gastroenterologist and the surgeon must be aware of the physiologic changes caused by the anatomic reconfiguration following surgery. Among the mechan...
Source: Revista Espanola de Enfermedades Digestivas - February 23, 2020 Category: Gastroenterology Tags: Rev Esp Enferm Dig Source Type: research

Iridoids of Valeriana fauriei contribute to alleviating hepatic steatosis in obese mice by lipophagy
Publication date: May 2020Source: Biomedicine & Pharmacotherapy, Volume 125Author(s): Da-Hye Lee, So-Hyun Park, Yang Hoon Huh, Min Jung Kim, Hyo-Deok Seo, Tae-Youl Ha, Jiyun Ahn, Young-Jin Jang, Chang Hwa JungAbstractNonalcoholic fatty liver disease (NAFLD) is a common risk factor for metabolic syndrome that increases the risk of future cardiovascular disease, stroke, and diabetes. Recently, autophagy has been proposed as a means to prevent NAFLD. We investigated whether substances with autophagy-inducing activity alleviate NAFLD. The Valeriana fauriei (V. fauriei) was selected as a potential autophagy inducer among variou...
Source: Biomedicine and Pharmacotherapy - February 12, 2020 Category: Drugs & Pharmacology Source Type: research

Iridoids of Valeriana fauriei contribute to alleviating hepatic steatosis in obese mice by lipophagy.
Abstract Nonalcoholic fatty liver disease (NAFLD) is a common risk factor for metabolic syndrome that increases the risk of future cardiovascular disease, stroke, and diabetes. Recently, autophagy has been proposed as a means to prevent NAFLD. We investigated whether substances with autophagy-inducing activity alleviate NAFLD. The Valeriana fauriei (V. fauriei) was selected as a potential autophagy inducer among various natural materials using a Cyto-ID autophagy detection kit. V. fauriei 70 % ethanol extract (VFE) increased LC3II levels in the presence of the lysosomal inhibitor and reduced the GFP/mCherry puncta...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - February 9, 2020 Category: Drugs & Pharmacology Authors: Lee DH, Park SH, Huh YH, Jung Kim M, Seo HD, Ha TY, Ahn J, Jang YJ, Jung CH Tags: Biomed Pharmacother Source Type: research

Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany
ConclusionsNAFLD constitutes an independent risk factor for CHD, MI, and AF in primary care in Germany. Identification of patients with NAFLD in primary care will allow specifically managing and modifying underlying risk factors to improve the overall prognosis.
Source: Digestive Diseases and Sciences - December 2, 2019 Category: Gastroenterology Source Type: research

Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes.
CONCLUSION: - These results suggest that NAFLD and significant LF (as assessed by FibroScan) are very commonly seen in T2DM outpatients with no known liver disease attending a secondary-care diabetes service, and that increased LF is associated with a greater proportion of chronic vascular complications, especially CKD. PMID: 31786361 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism - November 27, 2019 Category: Endocrinology Authors: Mantovani A, Turino T, Lando MG, Gjini K, Byrne CD, Zusi C, Ravaioli F, Colecchia A, Maffeis C, Salvagno G, Lippi G, Bonora E, Targher G Tags: Diabetes Metab Source Type: research

Nonalcoholic fatty liver disease with advanced fibrosis, stroke and cardiovascular disease
Parikh et al. conducted a cross-sectional study on the relationship of nonalcoholic fatty liver disease with advanced fibrosis (NAFLD-fibrosis) with stroke, heart disease, and major cardiovascular disease [1]. As indicators of NAFLD-fibrosis, the Fibrosis-4 Score (FIB-4) and NAFLD Fibrosis Score (NFS) were used for the analysis. Adjusted odds ratio (OR) (95% confidence interval [CI]) of the FIB-4 for stroke was 1.87 (1.00 –3.50). In addition, adjusted ORs of NAFLD-fibrosis for heart disease and major cardiovascular disease significantly increased.
Source: Journal of the Neurological Sciences - November 6, 2019 Category: Neurology Authors: Tomoyuki Kawada Tags: Letter to the Editor Source Type: research

Response to letter to the editor by Kawada on “Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke”
We thank Dr. Kawada for their interest [1] in our recent publication [2], in which we reported on the association between nonalcoholic fatty liver disease (NAFLD) fibrosis indices and stroke. In a large, nationally representative sample of Americans, we demonstrated a cross-sectional relationship between NAFLD-advanced fibrosis and prevalent, self-reported stroke, with variability in our findings depending on the liver fibrosis score used.
Source: Journal of the Neurological Sciences - November 6, 2019 Category: Neurology Authors: NealS. Parikh, Jose Gutierrez Tags: Letter to the Editor Source Type: research

Association between iron metabolism and cognitive impairment in older non-alcoholic fatty liver disease individuals: A cross-sectional study in patients from a Chinese center
This study examined whether iron metabolism is associated with cognitive impairment in older individuals. A cross-sectional study was held in patients from a Chinese center. Individuals with NAFLD aged over 60 years were included if they did not have excessive alcohol intake and were free of stroke or dementia. Their cognitive function was assessed by the same neurologist. 3.0T H proton magnetic resonance spectroscopy (1H-MRS) was performed to evaluate the hippocampus of the participants without contraindication. t test and Chi-square test were used to analyze the data. Binary logistic regression was used for correlation ...
Source: Medicine - November 1, 2019 Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research